ID   STBCi024-C
AC   CVCL_RB81
SY   SFC831-03-05; TPL1.3
DR   BioSamples; SAMEA104493655
DR   EBiSC; STBCi024-C
DR   ECACC; 66540690
DR   GEO; GSM2392426
DR   GEO; GSM2392489
DR   hPSCreg; STBCi024-C
DR   Wikidata; Q54956402
RX   PubMed=28827786;
CC   From: StemBANCC; Oxford; United Kingdom.
CC   Sequence variation: Gene amplification; HGNC; HGNC:11138; SNCA; Triplication; Zygosity=Unspecified (PubMed=28827786).
CC   Omics: Transcriptomics; Microarray.
CC   Discontinued: ECACC; 66540690; true.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C198604; Parkinson disease 4, autosomal dominant
DI   ORDO; Orphanet_411602; Hereditary late-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_A8Y1 ! SF831
SX   Female
AG   55Y
CA   Induced pluripotent stem cell
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 14
//
RX   PubMed=28827786; DOI=10.1038/s41598-017-09362-3; PMCID=PMC5567139;
RA   Haenseler W., Zambon F., Lee H., Vowles J., Rinaldi F., Duggal G.,
RA   Houlden H., Gwinn-Hardy K.A., Wray S., Luk K.C., Wade-Martins R.,
RA   James W.S., Cowley S.A.;
RT   "Excess alpha-synuclein compromises phagocytosis in iPSC-derived
RT   macrophages.";
RL   Sci. Rep. 7:9003-9003(2017).
//